Australian oncology research is ASCO Advance of the Year

The American Society for Clinical Oncology (ASCO) has featured an Australian trial of neoadjuvant therapy in melanoma as a part of its 2020 Advance of the Year in cancer. In its annual review, ASCO selected Refinement of Surgical Treatment of...

The American Society for Clinical Oncology (ASCO) has featured an Australian trial of neoadjuvant therapy in melanoma as a part...

Breast

Medicare high risk breast cancer screening MRIs not targeting the right women

Medicare-funded MRI breast screening of high risk women under 50 years is poorly targeted, a WA study suggests. The study compared the MRI screen-detected cancer prevalence in Medicare-eligible high risk women due to family history or...

Medicare-funded MRI breast screening of high risk women under 50 years is poorly targeted, a WA study suggests. ...

Breast

First birth achieved with fertility preservation using IVM oocytes in woman with cancer

The birth of the first baby to be born to an infertile cancer patient from an immature egg that was matured in the laboratory, frozen, then thawed and fertilised five years later has been announced by fertility specialists in France. A...

The birth of the first baby to be born to an infertile cancer patient from an immature egg that was...

Lung

SCLC patients to gain PBS access to immunotherapy

New PBS listings from 1 March will include the first immunotherapy (atezolizumab) subsidised for small cell lung cancer (SCLC) and durvalumab for NSCLC. Atezolizumab (Tecentriq, Roche) will be have its PBS listing expanded to include first-line treatment of patients with extensive-stage...

New PBS listings from 1 March will include the first immunotherapy (atezolizumab) subsidised for small cell lung cancer (SCLC) and...